Konrad Kubiński

Dr. Konrad Kubiński

Department of Molecular Biology, The John Paul Catholic University of Lublin
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Karol BiernackiKarol Biernacki
Karol Biernacki
MDMateusz Daśko
Mateusz Daśko
OCOlga Ciupak
Olga Ciupak
KKKonrad Kubiński
Konrad Kubiński
JRJanusz Rachon
Janusz Rachon
SDSebastian Demkowicz
Sebastian Demkowicz
Five-membered 1,2,4-oxadiazole heterocyclic ring has received considerable attention because of its unique bioisosteric properties and an unusually wide spectrum of biological activities. Thus, it is a perfect framework for the novel drug development. After a century since the 1,2,4-oxadiazole have been discovered, the uncommon potential attracted medicinal chemists’ attention, leading to the discovery of a few presently accessible drugs containing 1,2,4-oxadiazole unit. It is worth noting that the interest in a 1,2,4-oxadiazoles’ biological application has been doubled in the last fifteen years. Herein, after a concise historical introduction, we present a comprehensive overview of the recent achievements in the synthesis of 1,2,4-oxadiazole-based compounds and the major advances in their biological applications in the period of the last five years as well as brief remarks on prospects for further development.

18 January 2018 in Molecules
Verified
Journal Article
Open access
PDF file
PRPriscila López Rojas
Priscila López Rojas
MJMonika Janeczko
Monika Janeczko
KKKonrad Kubiński
Konrad Kubiński
ÁAÁngel Amesty
Ángel Amesty
MMMaciej Masłyk
Maciej Masłyk
Ana Estévez-BraunAna Estévez-Braun
Ana Estévez-Braun
A new series of coumarin-1,2,3-triazole conjugates with varied alkyl, phenyl and heterocycle moieties at C-4 of the triazole nucleus were synthesized using a copper(I)-catalysed Huisgen 1,3-dipolar cycloaddition reaction of corresponding O-propargylated coumarin (3) or N-propargylated coumarin (6) with alkyl or aryl azides. Based on their minimal inhibitory concentrations (MICs) against selected microorganisms, six out of twenty-six compounds showed significant antibacterial activity towards Enterococcus faecalis (MIC = 12.5–50 µg/mL). Moreover, the synthesized triazoles show relatively low toxicity against human erythrocytes.

8 February 2017 in Yeast
Verified
Journal Article
Open access
PDF file
MJMonika Janeczko
Monika Janeczko
MMMaciej Masłyk
Maciej Masłyk
KKKonrad Kubiński
Konrad Kubiński
HGHieronim Golczyk
Hieronim Golczyk
Emodin (1,3,8‐trihydroxy‐6‐methyl‐anthraquinone) is a natural secondary plant product, originally isolated from the rhizomes of Rheum palmatum. Many reports show its diuretic, vasorelaxant, antibacterial, antiviral, anti‐ulcerogenic, immunosuppressive, hepatoprotective, anti‐inflammatory and anticancer potential. Emodin is a pleiotropic molecule capable of interacting with several major molecular targets, e.g. NF‐κB, AKT/mTOR and STAT3. The compound can also act as an inhibitor of some protein kinases, with special affinity to protein kinase CK2. The aim of the presented report was to evaluate antifungal properties of emodin and its activity towards CK2 isolated from Candida cells. Our studies revealed that the compound suppressed growth of the cells of reference strains as well as clinical Candida strains, with minimal inhibitory concentration and minimal fungicidal concentration values between 12.5 and 200 μg/mL. Moreover, at a low concentration, the compound was able to effectively stop hyphal formation, thus showing a distinct antivirulent potential. Interestingly, we showed that emodin added to Candida culture inhibited the phosphorylation of many cellular proteins, presumably owing to the inhibition of protein kinase CK2. Notably, the enzyme isolated from the Candida cells was susceptible to emodin with IC50 of 2.8 μg/mL. Indeed, our computational modelling revealed that emodin was able to occupy the ATP‐binding pocket of CK2. Copyright © 2017 John Wiley & Sons, Ltd.

6 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Marta OlechMarta Olech
Marta Olech
Natalia Nowacka-JechalkeNatalia Nowacka-Jechalke
Natalia Nowacka-Jechalke
MMMaciej Masłyk
Maciej Masłyk
AMAleksandra Martyna
Aleksandra Martyna
WDWioleta Dołomisiewicz
Wioleta Dołomisiewicz
RNRenata Nowak
Renata Nowak
The huge health-beneficial potential of polysaccharides encourages the search for novel sources and applications of these compounds. One poorly explored source of polysaccharides is the rose. The content and biological activity of polysaccharides in rose organs is an almost completely unaddressed topic, therefore, polysaccharide-rich extracts (crude polysaccharides, CPLs) from petals, leaves, hips, and achenes of Rosa rugosa Thunb. were studied for their composition and the influence on various cellular processes involved in the development of cancer and other civilization diseases. The study revealed the presence of water-soluble and -insoluble polysaccharides (including β-glucans) and protein-polysaccharide conjugates in rose organs. Rose hips were found to be the most abundant source of polysaccharides. Different polysaccharide-rich extracts showed the ability to inhibit pro-inflammatory enzymes (COX-1, COX-2, hyaluronidase), a radical scavenging effect (against DPPH• and ABTS•+), and antiproliferative activity (in the A549 lung and SW480 colon cancer cell lines) in in vitro assays. Therefore, rose crude polysaccharides are very promising and can potentially be used as natural chemopreventive agents.

Verified
Journal Article
Open access
PDF file
MSMonika Medical Szewc
Monika Medical Szewc
ERElżbieta Radzikowska-Büchner
Elżbieta Radzikowska-Büchner
PWPaulina Wdowiak
Paulina Wdowiak
JKJoanna Kozak
Joanna Kozak
PKPiotr Kuszta
Piotr Kuszta
MMMaciej Masłyk
Maciej Masłyk
Mesenchymal stem cells (MSCs) are considered to be a powerful tool in the treatment of various diseases. Scientists are particularly interested in the possibility of using MSCs in cancer therapy. The research carried out so far has shown that MSCs possess both potential pro-oncogenic and anti-oncogenic properties. It has been confirmed that MSCs can regulate tumor cell growth through a paracrine mechanism, and molecules secreted by MSCs can promote or block a variety of signaling pathways. These findings may be crucial in the development of new MSC-based cell therapeutic strategies. The abilities of MSCs such as tumor tropism, deep migration and immune evasion have evoked considerable interest in their use as tumor-specific vectors for small-molecule anticancer agents. Studies have shown that MSCs can be successfully loaded with chemotherapeutic drugs such as gemcitabine and paclitaxel, and can release them at the site of primary and metastatic neoplasms. The inhibitory effect of MSCs loaded with anti-cancer agents on the proliferation of cancer cells has also been observed. However, not all known chemotherapeutic agents can be used in this approach, mainly due to their cytotoxicity towards MSCs and insufficient loading and release capacity. Quinazoline derivatives appear to be an attractive choice for this therapeutic solution due to their biological and pharmacological properties. There are several quinazolines that have been approved for clinical use as anticancer drugs by the US Food and Drug Administration (FDA). It gives hope that the synthesis of new quinazoline derivatives and the development of methods of their application may contribute to the establishment of highly effective therapies for oncological patients. However, a deeper understanding of interactions between MSCs and tumor cells, and the exploration of the possibilities of using quinazoline derivatives in MSC-based therapy is necessary to achieve this goal. The aim of this review is to discuss the prospects for using MSC-based cell therapy in cancer treatment and the potential use of quinazolines in this procedure.

22 December 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
KGKamila Górka
Kamila Górka
KKKonrad Kubiński
Konrad Kubiński
Silver nanoparticles have long been known for their antibacterial properties. Recently, increasing numbers of studies confirm that they have antifungal properties as well. Due to the increasing number of these studies, this review was performed, summarizing most of the research conducted so far in this field and presenting the results of the activity of silver nanoparticles against fungal pathogens of humans and plants, green synthesis of silver nanoparticles, and the mechanism of action. The combined activity with antifungal drugs and toxicity assessment is also presented. The review describes the antifungal activity of silver nanoparticles against pathogens such as F. oxysporum, F. graminearum, T. asahii, B. cinerea, P. concavum, and Pestalotia sp. as well as many species of the genus Candida. The green synthesis of these nanoparticles has been carried out from many species of plants and microorganisms. The research cited in this review confirms the fact that silver nanoparticles obtained using green synthesis exhibit antifungal activity and can therefore be an excellent alternative to the chemical synthesis of these particles. All this proves that silver nanoparticles have a great potential to be used as a potential antifungal agent in the future.